16-78425018-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016373.4(WWOX):​c.754C>G​(p.Pro252Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00893 in 1,614,016 control chromosomes in the GnomAD database, including 562 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 57 hom., cov: 32)
Exomes 𝑓: 0.0088 ( 505 hom. )

Consequence

WWOX
NM_016373.4 missense

Scores

10
8

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1B:9

Conservation

PhyloP100: 5.86

Publications

8 publications found
Variant links:
Genes affected
WWOX (HGNC:12799): (WW domain containing oxidoreductase) This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) protein family. This gene spans the FRA16D common chromosomal fragile site and appears to function as a tumor suppressor gene. Expression of the encoded protein is able to induce apoptosis, while defects in this gene are associated with multiple types of cancer. Disruption of this gene is also associated with autosomal recessive spinocerebellar ataxia 12. Disruption of a similar gene in mouse results in impaired steroidogenesis, additionally suggesting a metabolic function for the protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
WWOX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive spinocerebellar ataxia 12
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • developmental and epileptic encephalopathy, 28
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032241344).
BP6
Variant 16-78425018-C-G is Benign according to our data. Variant chr16-78425018-C-G is described in ClinVar as Benign. ClinVar VariationId is 380943.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.082 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WWOXNM_016373.4 linkc.754C>G p.Pro252Ala missense_variant Exon 7 of 9 ENST00000566780.6 NP_057457.1 Q9NZC7-1A0A411HBC7
WWOXNM_001291997.2 linkc.415C>G p.Pro139Ala missense_variant Exon 6 of 8 NP_001278926.1 Q9NZC7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WWOXENST00000566780.6 linkc.754C>G p.Pro252Ala missense_variant Exon 7 of 9 1 NM_016373.4 ENSP00000457230.1 Q9NZC7-1

Frequencies

GnomAD3 genomes
AF:
0.0102
AC:
1553
AN:
152124
Hom.:
58
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0388
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.0887
Gnomad SAS
AF:
0.0734
Gnomad FIN
AF:
0.00301
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000470
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.0235
AC:
5866
AN:
249540
AF XY:
0.0237
show subpopulations
Gnomad AFR exome
AF:
0.00161
Gnomad AMR exome
AF:
0.0562
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.0827
Gnomad FIN exome
AF:
0.00306
Gnomad NFE exome
AF:
0.000371
Gnomad OTH exome
AF:
0.0186
GnomAD4 exome
AF:
0.00880
AC:
12859
AN:
1461774
Hom.:
505
Cov.:
32
AF XY:
0.0103
AC XY:
7491
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.00105
AC:
35
AN:
33474
American (AMR)
AF:
0.0553
AC:
2471
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00409
AC:
107
AN:
26136
East Asian (EAS)
AF:
0.0782
AC:
3103
AN:
39700
South Asian (SAS)
AF:
0.0678
AC:
5846
AN:
86246
European-Finnish (FIN)
AF:
0.00281
AC:
150
AN:
53420
Middle Eastern (MID)
AF:
0.00299
AC:
17
AN:
5688
European-Non Finnish (NFE)
AF:
0.000288
AC:
320
AN:
1112004
Other (OTH)
AF:
0.0134
AC:
810
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
874
1748
2623
3497
4371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0102
AC:
1558
AN:
152242
Hom.:
57
Cov.:
32
AF XY:
0.0121
AC XY:
904
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.00125
AC:
52
AN:
41560
American (AMR)
AF:
0.0392
AC:
600
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3472
East Asian (EAS)
AF:
0.0887
AC:
457
AN:
5152
South Asian (SAS)
AF:
0.0730
AC:
351
AN:
4806
European-Finnish (FIN)
AF:
0.00301
AC:
32
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000470
AC:
32
AN:
68022
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
70
140
209
279
349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00437
Hom.:
17
Bravo
AF:
0.0110
ESP6500AA
AF:
0.000994
AC:
4
ESP6500EA
AF:
0.000478
AC:
4
ExAC
AF:
0.0231
AC:
2797
Asia WGS
AF:
0.0740
AC:
257
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000415

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:2
Jan 18, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jul 05, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Self-limited epilepsy with centrotemporal spikes Pathogenic:1
Jan 01, 2017
Bioinformatics Core, Luxembourg Center for Systems Biomedicine
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:case-control

CAADphred>15 -

Malignant tumor of esophagus;C3280452:Autosomal recessive spinocerebellar ataxia 12;C4015519:Developmental and epileptic encephalopathy, 28 Benign:1
Apr 05, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Autosomal recessive spinocerebellar ataxia 12;C3463992:Developmental and epileptic encephalopathy, 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 28 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive spinocerebellar ataxia 12 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.10
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.47
T;.;T
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.94
D;D;D
MetaRNN
Benign
0.0032
T;T;T
MetaSVM
Benign
-0.52
T
MutationAssessor
Benign
0.46
N;N;.
PhyloP100
5.9
PrimateAI
Uncertain
0.50
T
PROVEAN
Uncertain
-4.1
D;D;.
REVEL
Uncertain
0.56
Sift
Benign
0.33
T;T;.
Sift4G
Uncertain
0.056
T;T;T
Polyphen
0.79
P;.;.
Vest4
0.66
ClinPred
0.028
T
GERP RS
5.7
PromoterAI
-0.0072
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.27
gMVP
0.68
Mutation Taster
=7/93
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75559202; hg19: chr16-78458915; COSMIC: COSV68346014; COSMIC: COSV68346014; API